Consistently, injecting the STING agonist, cGAMP, into the tumor exhibited effective anti-tumor responses by recruiting and activating M1 phenotype TAMs in a STING-dependent manner via producing TNF-α, type I IFN, and T-cell-attracting chemokines to mediate various immune responses. This evidence concerns the gene STING1 and neoplasm.